NFKB1 and nasopharyngeal carcinoma: Liu et al. further demonstrated the ability of FLOT-2 to promote NF-κB and PI3K/Akt3 pathway activation and consequent metastatic progression in nasopharyngeal carcinoma (NPC) 15.